Trastuzumab Completed Phase 2 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00401427HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer
NCT00303108Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
NCT01401959Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
NCT01423695Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer
NCT00134680Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
NCT00490646A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer